发明授权
US09173907B2 Method of prenatal administration of mammalian umbilical cord stem cells for the intrauterine treatment of sanfilippo syndrome
有权
哺乳动物脐带干细胞产前给药方法,用于子宫内膜治疗Sanfilippo综合征
- 专利标题: Method of prenatal administration of mammalian umbilical cord stem cells for the intrauterine treatment of sanfilippo syndrome
- 专利标题(中): 哺乳动物脐带干细胞产前给药方法,用于子宫内膜治疗Sanfilippo综合征
-
申请号: US12168608申请日: 2008-07-07
-
公开(公告)号: US09173907B2公开(公告)日: 2015-11-03
- 发明人: Svitlana Garbuzova-Davis , Paul R. Sanberg , Sylvia Gografe
- 申请人: Svitlana Garbuzova-Davis , Paul R. Sanberg , Sylvia Gografe
- 申请人地址: US FL Tampa
- 专利权人: University of South Florida
- 当前专利权人: University of South Florida
- 当前专利权人地址: US FL Tampa
- 代理机构: Smith & Hopen, P.A.
- 代理商 Robert J. Varkonyi
- 主分类号: A61K35/44
- IPC分类号: A61K35/44
摘要:
A method of treating a fetus or embryo suspected of having a congenital condition that involves an abnormal or missing protein, the method has the steps of a. providing a plurality of human umbilical cord blood in a form suitable for intravenous administration; a b. administering the human umbilical cord blood cells to a mother carrying a fetus of embryo suspected of having said congenital condition. Such congenital conditions include Sanfilippo's syndrome, Hunter's syndrome, Hurler's syndrome, Tay-Sachs disease, Gaucher's disease, von Gierke's disease, Pompes disease, Cori disease, Andersen disease, McArdle's disease, Hers disease, Tauri's disease or Type IX glycogen storage disease.
公开/授权文献
信息查询
IPC分类: